• Je něco špatně v tomto záznamu ?

Celiac disease diagnosis in clinical practice: ESPGHAN quality of care survey from 129 pediatric hospitals across 28 countries

A. Litwin, TG. Le Thi, N. El-Lababidi, A. Kindermann, R. Pancheva, K. Gerasimidis, CC. Goncalves, PC. Escobar, T. Niseteo, K. Ikrath, S. Koletzko, Quality‐of‐Care Network

. 2025 ; 81 (3) : 606-617. [pub] 20250707

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25021791

Grantová podpora
ESPGHAN
Ludwig Maximilians Universität Munich

OBJECTIVES: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines recommend first-line serology for suspected celiac disease (CeD), measuring only transglutaminase antibodies (TGA-immunoglobulin A [IgA]) plus total IgA. If TGA-IgA is ≥10 times the normal value, pediatric gastroenterologists (pedGI) may diagnose CeD without biopsies if autoantibodies against endomysial antibodies (EMA-IgA) are positive in a 2nd blood sample. This Quality-of-Care (QoC) project benchmarked diagnostic workup in clinical practice using ESPGHAN CeD guidelines as reference. METHODS: A pseudonymized survey on CeD practices was sent to 141 hospitals within the ESPGHAN QoC-network in 28 countries. RESULTS: Questionnaires were completed by 129/141 (91.5%) hospitals, with 121 (94%) having pedGI staff. As reasons conflicting with good QoC for CeD in their setting, responders assumed knowledge deficits among the public (57%), primary care providers (64%), non-GI physicians (16%), and pedGIs (0%). For initial testing, 66% of physicians ordered only total IgA and TGA-IgA, 7% did not use this combination, and 29% ordered additional serology (TGA-IgG, EMA, antibodies against deaminated gliadin peptide, or native gliadin). Regarding conflicting results for TGA-IgA and histopathology in IgA-sufficient children, 61% incorrectly classified negative TGA-IgA with Marsh 2 and 57% with Marsh 3 lesions as "potential CeD," while 49% excluded CeD in the case of villous atrophy and negative TGA-IgA. Routine practice did not align with the ESPGHAN recommendations regarding performance of duodenal biopsies (27%), EMA-testing (34%), and diagnosis of CeD in IgA-deficient children (32%). CONCLUSIONS: We identified areas for improving QoC regarding both effectiveness and efficacy, in pediatric patients with suspected CeD, and consequently developed easy-to-use tools to improve guideline implementation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25021791
003      
CZ-PrNML
005      
20251023075841.0
007      
ta
008      
251014s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jpn3.70143 $2 doi
035    __
$a (PubMed)40621676
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Litwin, Anna $u Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany
245    10
$a Celiac disease diagnosis in clinical practice: ESPGHAN quality of care survey from 129 pediatric hospitals across 28 countries / $c A. Litwin, TG. Le Thi, N. El-Lababidi, A. Kindermann, R. Pancheva, K. Gerasimidis, CC. Goncalves, PC. Escobar, T. Niseteo, K. Ikrath, S. Koletzko, Quality‐of‐Care Network
520    9_
$a OBJECTIVES: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines recommend first-line serology for suspected celiac disease (CeD), measuring only transglutaminase antibodies (TGA-immunoglobulin A [IgA]) plus total IgA. If TGA-IgA is ≥10 times the normal value, pediatric gastroenterologists (pedGI) may diagnose CeD without biopsies if autoantibodies against endomysial antibodies (EMA-IgA) are positive in a 2nd blood sample. This Quality-of-Care (QoC) project benchmarked diagnostic workup in clinical practice using ESPGHAN CeD guidelines as reference. METHODS: A pseudonymized survey on CeD practices was sent to 141 hospitals within the ESPGHAN QoC-network in 28 countries. RESULTS: Questionnaires were completed by 129/141 (91.5%) hospitals, with 121 (94%) having pedGI staff. As reasons conflicting with good QoC for CeD in their setting, responders assumed knowledge deficits among the public (57%), primary care providers (64%), non-GI physicians (16%), and pedGIs (0%). For initial testing, 66% of physicians ordered only total IgA and TGA-IgA, 7% did not use this combination, and 29% ordered additional serology (TGA-IgG, EMA, antibodies against deaminated gliadin peptide, or native gliadin). Regarding conflicting results for TGA-IgA and histopathology in IgA-sufficient children, 61% incorrectly classified negative TGA-IgA with Marsh 2 and 57% with Marsh 3 lesions as "potential CeD," while 49% excluded CeD in the case of villous atrophy and negative TGA-IgA. Routine practice did not align with the ESPGHAN recommendations regarding performance of duodenal biopsies (27%), EMA-testing (34%), and diagnosis of CeD in IgA-deficient children (32%). CONCLUSIONS: We identified areas for improving QoC regarding both effectiveness and efficacy, in pediatric patients with suspected CeD, and consequently developed easy-to-use tools to improve guideline implementation.
650    _2
$a lidé $7 D006801
650    12
$a celiakie $x diagnóza $x krev $7 D002446
650    _2
$a dětské nemocnice $7 D006776
650    _2
$a imunoglobulin A $x krev $7 D007070
650    _2
$a autoprotilátky $x krev $7 D001323
650    _2
$a dítě $7 D002648
650    12
$a lékařská praxe - způsoby provádění $x statistika a číselné údaje $7 D010818
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a průzkumy a dotazníky $7 D011795
650    12
$a kvalita zdravotní péče $7 D011787
650    _2
$a transglutaminasy $x imunologie $7 D011503
650    _2
$a gastroenterologie $x normy $7 D005762
650    _2
$a průzkumy zdravotní péče $7 D019538
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Le Thi, Thu Giang $u Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany $u Stiftung Kindergesundheit, c/o Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany
700    1_
$a El-Lababidi, Nabil $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Kindermann, Angelika $u Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands
700    1_
$a Pancheva, Rouzha $u Department of Hygiene and Epidemiology, Faculty of Public Health, Prof. Paraskev Stoyanov Medical University, Varna, Bulgaria
700    1_
$a Gerasimidis, Konstantinos $u Human Nutrition, School of Medicine, University of Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland
700    1_
$a Goncalves, Cristina Campos $u Central Lisbon University Hospital Centre, Lisbon, Portugal
700    1_
$a Escobar, Paula Crespo $u i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain $u Unit of Nutrition and Obesity, Hospital Recoletas Campo Grande, Valladolid, Spain
700    1_
$a Niseteo, Tena $u Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia
700    1_
$a Ikrath, Katharina $u The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition, Geneva, Switzerland
700    1_
$a Koletzko, Sibylle $u Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, LMU Munich, Munich, Germany $u Department of Pediatrics, Gastroenterology and Nutrition, School of Medicine Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland $1 https://orcid.org/0000000323748778
710    2_
$a Quality‐of‐Care Network
773    0_
$w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 81, č. 3 (2025), s. 606-617
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40621676 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023075846 $b ABA008
999    __
$a ok $b bmc $g 2416913 $s 1259954
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 81 $c 3 $d 606-617 $e 20250707 $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
GRA    __
$p ESPGHAN
GRA    __
$p Ludwig Maximilians Universität Munich
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace